QURE – uniQure N.V.
Float Short %
15.79
Margin Of Safety %
Put/Call OI Ratio
0.25
EPS Next Q Diff
0.61
EPS Last/This Y
1.57
EPS This/Next Y
0.69
Price
23.06
Target Price
52.27
Analyst Recom
1.29
Performance Q
-60.15
Relative Volume
0.53
Beta
0.66
Ticker: QURE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-09 | QURE | 20.75 | 0.33 | 0.29 | 167641 |
| 2025-12-10 | QURE | 20.15 | 0.32 | 0.15 | 166871 |
| 2025-12-11 | QURE | 19.76 | 0.31 | 0.15 | 166875 |
| 2025-12-12 | QURE | 19.51 | 0.30 | 0.29 | 166410 |
| 2025-12-15 | QURE | 20.49 | 0.30 | 0.16 | 167013 |
| 2025-12-16 | QURE | 21.89 | 0.29 | 0.09 | 167603 |
| 2025-12-17 | QURE | 23.06 | 0.29 | 0.18 | 171409 |
| 2025-12-18 | QURE | 23.94 | 0.29 | 0.31 | 177557 |
| 2025-12-19 | QURE | 23.97 | 0.29 | 0.25 | 182730 |
| 2025-12-22 | QURE | 24.85 | 0.24 | 0.52 | 149963 |
| 2025-12-23 | QURE | 24.06 | 0.24 | 0.48 | 150762 |
| 2025-12-26 | QURE | 24.82 | 0.24 | 0.13 | 151430 |
| 2025-12-29 | QURE | 24.61 | 0.24 | 0.22 | 152631 |
| 2025-12-30 | QURE | 23.8 | 0.24 | 0.49 | 152912 |
| 2025-12-31 | QURE | 23.95 | 0.24 | 0.11 | 153034 |
| 2026-01-02 | QURE | 23.39 | 0.24 | 0.53 | 153188 |
| 2026-01-05 | QURE | 22.59 | 0.25 | 0.52 | 153472 |
| 2026-01-06 | QURE | 22.29 | 0.25 | 0.06 | 154033 |
| 2026-01-07 | QURE | 23.08 | 0.25 | 0.30 | 155538 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-09 | QURE | 20.78 | 44.7 | 36.6 | -3.30 |
| 2025-12-10 | QURE | 20.13 | 44.9 | 33.4 | -3.30 |
| 2025-12-11 | QURE | 19.78 | 44.9 | 29.9 | -3.35 |
| 2025-12-12 | QURE | 19.52 | 44.9 | 28.2 | -3.35 |
| 2025-12-15 | QURE | 20.43 | 44.9 | 11.6 | -3.35 |
| 2025-12-16 | QURE | 20.43 | 44.9 | 25.8 | -3.35 |
| 2025-12-17 | QURE | 23.05 | 44.9 | 11.6 | -3.35 |
| 2025-12-18 | QURE | 23.93 | 44.9 | 15.5 | -3.35 |
| 2025-12-19 | QURE | 23.97 | 44.9 | 24.6 | -3.35 |
| 2025-12-22 | QURE | 24.71 | 44.9 | 17.1 | -3.35 |
| 2025-12-23 | QURE | 24.10 | 44.9 | 33.2 | -3.35 |
| 2025-12-26 | QURE | 24.81 | 44.9 | 28.4 | -3.35 |
| 2025-12-29 | QURE | 24.57 | 44.9 | 27.2 | -3.35 |
| 2025-12-30 | QURE | 23.80 | 44.9 | 32.3 | -3.35 |
| 2025-12-31 | QURE | 23.94 | 44.9 | 23.4 | -3.35 |
| 2026-01-02 | QURE | 23.44 | 44.9 | 29.9 | -3.35 |
| 2026-01-05 | QURE | 22.60 | 44.9 | 33.1 | -3.35 |
| 2026-01-06 | QURE | 22.30 | 44.9 | 28.4 | -3.35 |
| 2026-01-07 | QURE | 23.06 | 44.9 | 16.6 | -3.35 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-09 | QURE | -6.51 | -6.74 | 14.78 |
| 2025-12-10 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-11 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-12 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-15 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-16 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-17 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-18 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-19 | QURE | -6.51 | -6.74 | 14.68 |
| 2025-12-22 | QURE | -6.42 | -6.68 | 14.68 |
| 2025-12-23 | QURE | -6.42 | -6.68 | 14.68 |
| 2025-12-26 | QURE | -6.13 | -6.68 | 15.79 |
| 2025-12-29 | QURE | -6.13 | -6.63 | 15.79 |
| 2025-12-30 | QURE | -6.13 | -6.63 | 15.79 |
| 2025-12-31 | QURE | -6.13 | -6.63 | 15.79 |
| 2026-01-02 | QURE | -6.11 | -6.63 | 15.79 |
| 2026-01-05 | QURE | -6.11 | -6.62 | 15.79 |
| 2026-01-06 | QURE | -6.11 | -6.62 | 15.79 |
| 2026-01-07 | QURE | -6.11 | -6.62 | 15.79 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.38
Avg. EPS Est. Current Quarter
-0.8
Avg. EPS Est. Next Quarter
-0.77
Insider Transactions
-6.11
Institutional Transactions
-6.62
Beta
0.66
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
40
Growth Score
32
Sentiment Score
44
Actual DrawDown %
67.8
Max Drawdown 5-Year %
-91
Target Price
52.27
P/E
Forward P/E
PEG
P/S
90.27
P/B
6.27
P/Free Cash Flow
EPS
-4.39
Average EPS Est. Cur. Y
-3.35
EPS Next Y. (Est.)
-2.66
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1492.9
Relative Volume
0.53
Return on Equity vs Sector %
-129.9
Return on Equity vs Industry %
-114.7
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.59
EBIT Estimation
16.6
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 209
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading